title: The promise of rapidly acting antidepressants: challenges and opportunities.
authors: AstraZeneca Pharmaceuticals, 1800 Concord Pike, Wilmington, DE 19803, USA. mark.a.smith@astrazeneca.com
authors: Mark A
authors: MA
authors: Smith
authors: Sanjeev
authors: S
authors: Pathak
mesh_terms: D000928:Antidepressive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy*; D055808:Drug Discovery; D006801:Humans; D007649:Ketamine / Q000494:pharmacology* / Q000627:therapeutic use; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*
chemical_list: D000928:Antidepressive Agents; D016202:N-Methylaspartate; D007649:Ketamine